# Rein Therapeutics (RNTX): Quarterly Results, a 27.5% Drop

> Source: IndicatorStack, https://indicatorstack.com/catalysts/rntx-2026-11-16-earnings. Updated Nov 19, 2026, 4:40 AM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

Rein Therapeutics (RNTX) announced preliminary blinded Phase 2 RENEW data at 7:30 AM ET on Monday, November 16, and the stock went from Friday’s $0.5521 close to as low as $0.2844. It finished the session −27.5% at $0.4000 on 24.3 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.

Catalyst Reaction by IndicatorStack, published Nov 19, 2026, 4:10 AM ET. NASDAQ: RNTX, Biotechnology. All times ET.

## The numbers

- −27.5% Monday’s close ($0.5521 to $0.4000, low $0.2844)
- 24.3× its 20-day average volume (8.5M shares on the day)
- 7:30 AM the catalyst crossed, ET (Monday, before the open)
- 66.1M float, shares (13% of the float traded on Monday)

## How the stack read it, checkpoint by checkpoint

| Checkpoint | When | Price | 5m stack bias | Compass |
| --- | --- | --- | --- | --- |
| Before | Fri close | $0.5534 | Neutral | 15m and 1h split |
| Into the open | Mon 9:30 AM | $0.4999 | Bearish, firm | 15m and 1h down |
| 30 minutes in | Mon 10:00 AM | $0.3651 | Bearish, weakening | 15m and 1h down |
| At the close | Mon 4:00 PM | $0.4023 | Bearish, weakening | 15m and 1h down |
| Tuesday’s close | Tue 4:00 PM | $0.3604 | Bullish, weakening | 15m and 1h still down |
| Wednesday’s close | Wed 4:00 PM | $0.3619 | Bearish, weakening | 15m and 1h split |

## Timeline

### Monday, November 16

- 6:40 AM: Quarterly report (Form 10-Q) filed (Accepted by the SEC at 6:40:46 AM ET)
- 7:30 AM: Preliminary blinded Phase 2 RENEW data (Press release, GlobeNewsWire)
- 7:55 AM: Premarket high $0.6450 (+16.8% from the prior close)
- 8:37 AM: Current report (Form 8-K) filed (Accepted by the SEC at 8:37:54 AM ET)
- 9:10 AM: 5-minute stack bias turned bearish (at $0.5029)
- 9:30 AM: Opened at $0.5000 (−9.4% from Friday’s $0.5521 close)
- 9:45 AM: Session low $0.2844
- 9:45 AM: Tripwire flagged a trap at the lows (a push through support that failed to hold, at $0.3000)
- 12:20 PM: Tripwire flagged a trap at the highs (a push through resistance that failed to hold, at $0.4201)
- 1:45 PM: Trigger marked a short at $0.4011 (Hypothetical, default settings: reached $0.3880 at 2:05 PM for +1.1R (volume flow turned up))
- 2:40 PM: Trigger marked a short at $0.3771 (Hypothetical, default settings: closed at $0.3924 at 2:45 PM for −1.2R (stop))
- 4:00 PM: Closed at $0.4000, −27.5% on the day (8.5M shares, 24.3× its 20-day average)

### Tuesday, November 17

- 9:30 AM: Opened at $0.3800 (−5.0% from Monday’s $0.4000 close)
- 2:40 PM: Session low $0.3249
- 3:15 PM: 5-minute stack bias went neutral (at $0.3701, its inputs no longer agreeing)
- 3:25 PM: 5-minute stack bias turned bullish (at $0.3745)
- 4:00 PM: Closed at $0.3564, −10.9% on the day (2.5M shares, 3.3× its 20-day average)

### Wednesday, November 18

- 9:30 AM: Opened at $0.3660 (+2.7% from Tuesday’s $0.3564 close)
- 1:00 PM: 5-minute stack bias went neutral (at $0.3709, its inputs no longer agreeing)
- 1:35 PM: Trigger marked a short at $0.3630 (Hypothetical, default settings: reached $0.3566 at 2:50 PM for +1.1R (reclaimed VWAP or the fast EMA))
- 1:40 PM: 5-minute stack bias turned bearish (at $0.3656)
- 2:20 PM: Session low $0.3496
- 4:00 PM: Closed at $0.3553, −0.3% on the day (816K shares, 1.0× its 20-day average)

## Before the catalyst (Friday, November 13)

Rein Therapeutics closed Friday at $0.5521. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h split” (15m ↗ 1h ↘ 2h ↘ 4h ↘ D ↓). Undertow: hidden buying, price lower, flow higher. Tripwire: Longs: Clean, nothing major in the way. Its Next row read “Range 0.5333 to 0.5683, no edge in the middle”.

Over the year before, it had traded between $0.5010 and $2.10.

## The quarterly results and a 27.5% drop (Monday, November 16)

The release crossed at 7:30 AM ET, with the company’s Form 8-K accepted by the SEC at 8:37 AM. It opened at $0.5000, −9.4%, and the regular session ranged from $0.2844 to $0.5000 before closing at $0.4000. It did this on a day SPY fell 1.9% and XBI, the biotechnology ETF, fell 3.1%.

Into the open the stack read it as bearish (firm) with 2 of 2 higher timeframes down, and Undertow read “sellers in control”. Thirty minutes in, the picture had changed: price held above VWAP at $0.3488 and the Next row read “Bounce, resistance to hold at 0.4113 (slow EMA)”. By the close the 5-minute bias was bearish from 9:10 AM, while Compass still read “15m and 1h down”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.

## The session after (Tuesday, November 17)

It opened at $0.3800 (−5.0%) and traded from $0.3249 to $0.4050, closing at $0.3564, −10.9% on 2.5M shares, still 3.3 times its 20-day average. The 5-minute stack bias was bullish (weakening), since 3:25 PM: momentum up, net buying and trend strength with the buyers. Compass read “15m and 1h still down” (15m ↘ 1h ↓ 2h ↓ 4h ↘ D ↓). Undertow: buyers in control, real size behind the push. Tripwire: Longs: Clean, nothing major in the way.

## The session after (Wednesday, November 18)

It opened at $0.3660 (+2.7%) and traded from $0.3496 to $0.3899, closing at $0.3553, −0.3% on 816K shares, still 1.0 times its 20-day average. The 5-minute stack bias was bearish (weakening), since 1:40 PM: under VWAP 0.3691 and a falling SMA, momentum down. Compass read “15m and 1h split” (15m ↗ 1h ↘ 2h ↘ 4h ↓ D ↘). Undertow: buyers pushing back, flow turning against the bias. Tripwire: Shorts: Avoid, resistance looks thin, buying tape on it.

After hours it last traded at $0.3553, with Undertow reading “buyers pushing back”.

## Supply

|  |  |  |
| --- | --- | --- |
| Shares outstanding | 86.3M | as reported to the SEC |
| Float | 66.1M | 77% of shares outstanding |
| Reverse splits on record | 1 | 1-for-20 reverse split, November 11, 2022 |
| Last insider purchase | May 27, 2026 | 5K shares at $1.07 by VON RICKENBACH JOSEF H (director) |

## Sources

- Mon Nov 16, 8:37 AM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1420565/000119312526462261/d159635dex991.htm
- Mon Nov 16, 7:30 AM ET, Press release: Preliminary blinded Phase 2 RENEW data (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/16/3403389/28652/en/rein-therapeutics-announces-preliminary-blinded-phase-2-renew-data-showing-encouraging-lung-function-trends-in-patients-with-idiopathic-pulmonary-fibrosis-and-reports-third-quarter.html
- Mon Nov 16, 6:40 AM ET, SEC filing: Quarterly report (Form 10-Q) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1420565/000119312526461944/rntx-20260930.htm

## Questions

### Why did RNTX stock go down on November 16?

Rein Therapeutics (RNTX) announced preliminary blinded Phase 2 RENEW data at 7:30 AM ET on Monday, November 16, and the stock went from Friday’s $0.5521 close to as low as $0.2844. It finished the session −27.5% at $0.4000 on 24.3 times its 20-day average volume. The reaction describes the sequence and infers no cause.

### What did Rein Therapeutics announce on November 16, 2026?

Rein Therapeutics (RNTX) announced preliminary blinded Phase 2 RENEW data at 7:30 AM ET on Monday, November 16.

### How did RNTX stock trade on November 16?

RNTX opened at $0.5000, −9.4% from the prior close of $0.5521, traded between $0.2844 and $0.5000 in the regular session and closed at $0.4000, −27.5%, on 8.5M shares.

### How did LiveChart’s stack read RNTX at the close on November 16?

At the 4:00 PM ET close the 5-minute stack bias on RNTX was bearish (weakening), Compass read “15m and 1h down” and Undertow read “sellers in control”. Each turn of the read is on this page’s timeline.

### What does LiveChart’s stack read on RNTX now?

The read on this page is fixed at each moment it describes. LiveChart reads RNTX on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.

Chart: https://indicatorstack.com/chart/RNTX. RNTX catalyst history: https://indicatorstack.com/catalysts/stock/RNTX

Each reaction describes what happened and when, infers no cause and takes no view on what comes next. Past reactions don’t predict future ones.

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
